ClinicalTrials.Veeva

Menu

Pediatric Bipolar Disorder Study at UCLA

University of California, Los Angeles (UCLA) logo

University of California, Los Angeles (UCLA)

Status

Completed

Conditions

Bipolar Disorder

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT00961935
P50MH077248-02 (U.S. NIH Grant/Contract)
DNBBS B2-MBP (Other Grant/Funding Number)

Details and patient eligibility

About

The UCLA Semel Institute for Neuroscience in Los Angeles, CA, is conducting a study looking at similarities and differences in how the brain works between bipolar disorder and attention deficit hyperactivity disorder (ADHD).

Full description

Children between the ages of 7 and 17 years old, with a diagnosis of Bipolar I, Bipolar II, or Bipolar NOS, are currently being recruited for this study looking at similarities and differences in how the brain works between bipolar disorder and attention deficit hyperactivity disorder (ADHD). The study involves a comprehensive evaluation at intake, cognitive assessment, EEG, and functional MRI, done over the course of 2 or 3 visits. This study does not provide treatment. However, with participants' consent, the assessment information can be shared with the child's clinician or psychiatrist and a letter with the results from cognitive testing can be prepared, which can be useful in school planning. Referrals for treatment can also be provided.

Enrollment

50 patients

Sex

All

Ages

7 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subject suffers clinically impairing symptoms of mood lability.
  • Child has resided with primary caretaker for at least 6 months.
  • Caretaker speaks sufficient English to complete all study evaluations and measures.

Exclusion criteria

  • Lifetime history of mental retardation, autism, or primary diagnosis of psychosis.
  • Subject is pregnant or nursing.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems